Filing Details

Accession Number:
0001123292-15-000717
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-21 20:10:44
Reporting Period:
2015-04-21
Filing Date:
2015-04-21
Accepted Time:
2015-04-21 20:10:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437786 Immune Design Corp. IMDZ Pharmaceutical Preparations (2834) 262007174
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216504 W Lewis Coleman C/o Immune Design Corp.
1616 Eastlake Ave. E., Suite 310
Seattle WA 98102
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-04-21 10,000 $26.50 10,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Reflects the purchase of shares in the follow-on offering of common stock of Immune Design Corp. that closed on April 21, 2015.